Cargando…
Counterpoint: The value of benchmarking in observational studies of the longer term safety of antenatal corticosteroids
Autores principales: | Hutcheon, Jennifer A., Liauw, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107235/ https://www.ncbi.nlm.nih.gov/pubmed/36482791 http://dx.doi.org/10.1111/ppe.12937 |
Ejemplares similares
-
Antenatal corticosteroids and COVID-19: balancing benefits and harms
por: Liauw, Jessica, et al.
Publicado: (2020) -
Point: Antenatal corticosteroid treatment in the late preterm period—Are the benefits worth the potential risks?
por: Kajantie, Eero
Publicado: (2022) -
Antenatal corticosteroid administration and early school age child development: A regression discontinuity study in British Columbia, Canada
por: Hutcheon, Jennifer A., et al.
Publicado: (2020) -
Antenatal corticosteroid administration and attention-deficit/hyperactivity disorder in childhood: a regression discontinuity study
por: Hutcheon, Jennifer A., et al.
Publicado: (2022) -
Opposition: Unfractionated heparin should no longer be used in the catheterization laboratory
por: Kim, Moo Hyun, et al.
Publicado: (2014)